View this email in your browser



What’s Really at Stake in the Supreme Court Obamacare Challenge

Newsmax | Sally C. Pipes
June 9, 2021

Regardless of what the court decides, Obamacare has failed on the merits. People who shop on the exchanges created by the law have had to deal with surging premiums and deductibles that provide them access to narrow networks of doctors and hospitals. The cost of the law to taxpayers has been roughly double what President Obama promised. And millions of people are still uninsured.



Dr. Henry Miller Joins the John Batchelor Show to Discuss Coronavirus Research

The John Batchelor Show | Henry Miller, M.S., M.D.
June 7, 2021

Dr. Henry Miller, physician, molecular biologist, and PRI senior fellow joins the John Batchelor Show to discuss what the scientific community has learned about the family of coronaviruses, what’s next for COVID-19 treatments and vaccines, and how humans have fared under different forms of the coronavirus.



Don’t be fooled by Biden’s victory lap on Obamacare

The Washington Examiner | Sally C. Pipes
June 10, 2021

The Congressional Budget Office estimates that these new subsidies will cost more than $34 billion, with most of that bill hitting next year. About 1.3 million people who were previously uninsured will gain coverage. That’s a tab of more than $16,800 per newly insured person.

Read more. . .



COVID-19 Vaccines Will Not Be Enough. We Also Need Effective Treatments

American Council on Science and Health | Henry Miller, M.S., M.D.
June 9, 2021

Fourth, in view of the above, the best-case scenario is probably that COVID-19 will not in the foreseeable future completely disappear but will become endemic like influenza virus and the coronaviruses that can cause the common cold. In order to save lives and modulate the severity of future COVID-19 infections, it will be critical to develop safe and effective treatments in addition to vaccines.
Copyright © 2021 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104



Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.